Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Wegovy and Zepbound, typically have higher retail prices than Ozempic, ranging from $1,250 to $1,600. However, a new program from LillyDirect allows consumers to get 2.5- mg or 5-mg doses for $399 ...

The 2.5mg vial is available at $399 per month. Lilly claims the single-dose versions cost at least 50% less than the list price of other incretin medicines for obesity. "Offering Zepbound single ...

Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that it said would make it easier for people paying for the drug out-of-pocket to afford treatment.

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

Eli Lilly inked two collaborations on Monday, one focused on cardiometabolic diseases with South Korea’s OliX Pharmaceuticals ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Its lineup features several blockbusters, including its popular diabetes and weight loss medicines, Mounjaro and Zepbound ... compared to $1.2 billion in 2023. That would be an increase of ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...